CORRECTION article

Front. Oncol., 13 September 2024

Sec. Gastrointestinal Cancers

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1476176

Corrigendum: Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level

  • JH

    Jinhua He 1

  • FW

    Feifeng Wu 2

  • ZH

    Zeping Han 1

  • MH

    Min Hu 2

  • WL

    Weida Lin 2

  • YL

    Yuguang Li 1*

  • MC

    Mingrong Cao 2*

  • 1. Department of Laboratory Medicine, Central Hospital of Panyu District, Guangzhou, China

  • 2. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China

In the published article, there was an error. There is a clerical error in our article. On the page 5, the word “increase” should actually be “decrease”. So, it should read, “The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”

A correction has been made to Candidate RNA Molecules as Biomarkers for CRC.

lncRNAs as Biomarkers for CRC, Paragraph 3. This sentence previously stated:

“The upregulation of CCAT1 expression increases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”

The corrected sentence appears below:

“The upregulation of CCAT1 expression decreases sensitivity to fluorouracil chemotherapy, whereas its downregulation effectively reverses the resistance of colon cancer cell lines to fluorouracil, thereby opening up a new approach for the treatment of colon cancer.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

colorectal cancer, circulating tumor cell, circulating tumor DNA, circulating tumor miRNA, exosomes

Citation

He J, Wu F, Han Z, Hu M, Lin W, Li Y and Cao M (2024) Corrigendum: Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of colorectal cancer - from the body fluid to tissue level. Front. Oncol. 14:1476176. doi: 10.3389/fonc.2024.1476176

Received

23 August 2024

Accepted

30 August 2024

Published

13 September 2024

Volume

14 - 2024

Edited and reviewed by

Liang Qiao, The University of Sydney, Australia

Updates

Copyright

*Correspondence: Mingrong Cao, ; Yuguang Li,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics